Probing Perturbation of Bovine Lung Surfactant Extracts by Albumin using DSC and 2H-NMR  by Nag, Kaushik et al.
Probing Perturbation of Bovine Lung Surfactant Extracts by Albumin
using DSC and 2H-NMR
Kaushik Nag,*y Kevin M. W. Keough,* and Michael R. Morrowy
*Department of Biochemistry, and yDepartment of Physics & Physical Oceanography, Memorial University of Newfoundland, St. John’s,
Newfoundland, Canada
ABSTRACT Lung surfactant (LS), a lipid-protein mixture, forms ﬁlms at the lung air-water interface and prevents alveolar
collapse at end expiration. In lung disease and injury, the surface activity of LS is inhibited by leakage of serum proteins such as
albumin into the alveolar hypophase. Multilamellar vesicular dispersions of a clinically used replacement, bovine lipid extract
surfactant (BLES), to which (2% by weight) chain-perdeuterated dipalmitoylphosphatidycholine (DPPG mixtures-d62) had been
added, were studied using deuterium-NMR spectroscopy (2H-NMR) and differential scanning calorimetry (DSC). DSC scans of
BLES showed a broad gel to liquid-crystalline phase transition between 10–35C, with a temperature of maximum heat ﬂow
(Tmax) around 27C. Incorporation of the DPPC-d62 into BLES-reconstituted vesicles did not alter the Tmax or the transition
range as observed by DSC or the hydrocarbon stretching modes of the lipids observed using infrared spectroscopy. Transition
enthalpy change and 2H-NMR order parameter proﬁles were not signiﬁcantly altered by addition of calcium and cholesterol to
BLES. 2H-NMR spectra of the DPPC-d62 probes in these samples were characteristic of a single average lipid environment at
all temperatures. This suggested either continuous ordering of the bilayer through the transition during cooling or averaging of
the DPPC-d62 environment by rapid diffusion between small domains on a short timescale relative to that characteristic of the
2H-NMR experiment. Addition of 10% by weight of soluble bovine serum albumin (1:0.1, BLES/albumin, dry wt/wt) broadened
the transition slightly and resulted in the superposition of 2H-NMR spectral features characteristic of coexisting ﬂuid and ordered
phases. This suggests the persistence of phase-separated domains throughout the transition regime (5–35C) of BLES with
albumin. The study suggests albumin can cause segregation of protein bound-lipid domains in surfactant at NMR timescales
(105 s). Persistent phase separation at physiological temperature may provide for a basis for loss of surface activity of
surfactant in dysfunction and disease.
INTRODUCTION
Pulmonary or lung surfactant (LS) is a lipid-protein complex
secreted at the air-alveolar interface by type II pneumocytes
of the alveoli (1). The material forms a putative surface-
active monolayer with underlying multilayered structures to
reduce the surface tension of the ﬂuid coating of the terminal
alveolar airspace at low lung volumes (1–3). LS is also found
in airways, such as bronchioles, and likely prevents ﬂuid
retention in the narrow capillaries (4,5). In lung injuries,
including acute respiratory distress syndromes (ARDS), the
surface activity of the material is inhibited due to interactions
with plasma protein that has leaked into the alveolar airspace
(6,7). The surface activity properties of LS extracted from
ARDS lungs and the effects of individual serum proteins
(SP) such as albumin, hemoglobin, C-reactive protein, and
phospholipases on LS have been studied extensively (8).
Despite this effort, the physical characteristics of LS-SP sys-
tems as well as the speciﬁc modes of interactions of these
soluble proteins with LS lipids are not yet clear. Most
previous studies on interactions of SP with LS by measure-
ment of surface activity have used relatively large amounts
of SPs at ratios of 1:10 and 1:20 (surfactant lipids/protein,
wt/wt) to show maximal inhibitions of LS (8). Estimates of
such proteins from washings of diseased or injured lungs are
rarely as high (6,7,9). In this study we have examined the
interaction of a soluble inhibitory protein, bovine serum
albumin (BSA), at a small protein/lipid ratio (1:0.1, surfac-
tant lipids/albumin), with an exogenous bovine lipid extract
surfactant (BLES) used in the clinical treatment of ARDS
patients (10,11).
Most mammalian LS contains the disaturated lipid
dipalmitoylphosphatidycholine (DPPC) in large amounts, plus
monounsaturated phosphatidycholine (PC), phosphatidyl-
glycerol (PG), and neutral lipids in signiﬁcant amounts and
some associated proteins (10% by weight of lipids (3,10,11)).
The surfactant proteins SP-A and SP-D are large water-
soluble lectins, which are removed from most semisynthetic
and reconstituted LS used in clinical therapy. However the
smaller hydrophobic proteins, SP-B and SP-C, known to
enhance the surface activity of LS lipids as tested in vitro, are
present in most clinically used LS preparations (11). These
hydrophobic proteins, although present in fairly small amounts
(collectively comprising 2–3% by weight relative to LS
lipids), are known to critically enhance the surface activity
of LS at an air-water interface, as well as reduce inhibition
of surfactant by SPs (8,12–14). BLES is a clinically used LS
preparation from cow lung lavage, which contains all the
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phospholipid and protein components of LS, except the
soluble surfactant proteins SP-A and SP-D and neutral lipids
(i.e., cholesterol, triglycerides) (10). The composition as well
as the physical properties of BLES have been quite exten-
sively studied (10,15–18). This allows interactions between
various LS lipids and SP contaminants to be studied to model
dysfunctional LS. Also by addition or subtraction of materials
from BLES, speciﬁc interactions involving other LS com-
ponents (such as cholesterol, calcium ions, and SP-A) may
be studied (15,17,19).
Albumin is an SP responsible for binding and transport of
fatty acids in the blood (20). BSA is a 65-kDa protein having
hydrophobic pockets through which it binds to fatty acids
(21,22). BSA has 17 negatively charged amino acid residues
and is overall negatively charged at pH 7 (20). BSA is struc-
turally characteristic of globular-soluble proteins, which are
normally not found to interact with model or cellular mem-
branes (23,24). However albumin may interact with LS
bilayers at discontinuities, due to the coexistence of gel and
ﬂuid environments (18,25), or with the positively charged
SP-B. A number of previous studies show that rapid adsorp-
tion of LS to an air-water interface to form surface-active
ﬁlms is decreased by albumin and that ﬁlms formed in the
presence of albumin cannot reach low surface tension upon
compression (8,12,17,26,27). In ARDS the level of this SP is
found to reach higher levels in lung lavage compared to other
SPs, likely reﬂecting its high abundance in plasma (7,9).
In previous studies it was shown that a number of mam-
malian LS as well as their hydrophobic extracts in hydrated
bilayer dispersions undergo broad calorimetrically measurable
phase transitions.Thisphase change, possibly liquid-crystalline
to gel, has been normally detected between 10–40C, with tran-
sitionmidpoints and temperatures of maximal heat ﬂow (Tmax)
around 25–30C, close to that of BLES at;27C. (28–31). In
recent studies it was found that imaging of LS bilayers in the
liquid-crystalline to gel transition range can showmacroscopic
coexistence of gel and ﬂuid domains. These domains in LS
bilayers were detected by ﬂuorescence microscopy using
ﬂuorescence probes in free-standing giant unilamellar (GUV)
or multilamellar (MLV) vesicles (25) as well as in monolayers
(32–35). The gel domains in bilayers are present up to high
temperatures (18,33,35). A recent study has also shown the
presence of liquid-ordered (Lo) and liquid-disordered phases in
LS bilayers that contained a slight increase of cholesterol (25).
These phases are found normally in cell membrane ‘‘lipid
rafts’’ (25,34). Knowledge of how interactions of speciﬁc
additives inﬂuence hydrocarbon chain order in LS within the
phase coexistence regime can provide information on the struc-
tural basis for their ability to modify surfactant function. Some
studies have suggested that the domain structural organization
of LS ﬁlm is highly susceptible to small amounts of additives
such as cholesterol, calcium ions, and some serum constituents,
as well as through pH change (33,36).
Deuterium NMR (2H-NMR) is a valuable tool for
studying interactions of various lipid and protein compo-
nents of membranes (37–39) and has also been applied to
models of LS (40,41). Although 2H-NMR has been used
extensively for studies of model membrane systems, there
have also been some applications of it to material extracted
from natural membranes with small amounts of perdeuter-
ated lipids (PDLs) inserted as probe (42–45). Lipid diffusion
during the 2H-NMR experiment normally may preclude the
resolving of signals from protein-perturbed and -unperturbed
lipid populations. There have also been some reports of strong
complexation between protein and speciﬁc lipids giving rise
to slow exchange between free and bound PDL that lead to
resolution of different populations of deuterated lipids (46,47).
These observations have been discussed in terms of forma-
tion of domains which exist over 10–100-ms timescales.
Observation of boundary phases of the domains has also
been reported (47).
The interactions of various surfactant lipid-protein com-
ponents have been studied using 2H-NMR in simpliﬁed
models of LS (48). Since some recent studies have shown
coexistence of gel and ﬂuid domains in BLES at or near
mammalian physiological temperatures of 37C (18,25), an
attempt is made here to investigate the phase transition
process in this complex LS extract, BLES, using 2H-NMR.
The effects of cholesterol, calcium, and the inhibitory protein
albumin on phase separation, as seen on the 2H-NMR time-
scale (106–104 s), are studied. After adding a small amount
of the PDL, DPPC-d62 (2% by weight) to the vesicular sys-
tem of BLES, such systems are investigated using 2H-NMR.
The 2H-NMR observations are correlated with DSC heat
ﬂow proﬁles. The results suggest that although adding cho-
lesterol and calcium had only minor effects on the gel and
liquid-crystal properties of BLES, the presence of albumin
altered the phase distributions and the lipid order parameters.
This indicated possible albumin-induced formation of gel
and liquid-crystal domains that persist at least on microsec-
ond timescales over a transition range where no distinct phase
separation is obvious in BLES alone. Aspects of LS dys-
function likely reﬂect perturbation of surfactant bilayer or-
ganization by SPs such as albumin.
MATERIALS AND METHODS
Materials
The clinically used BLES in saline dispersion (27 mg/ml) was a generous
gift from BLES Biochemicals (London, Canada). Delipidated BSA, cho-
lesterol, and calcium chloride were purchased from Sigma Chemicals (St.
Louis, MO). DPPC-d62 was purchased from Avanti Polar Lipids (Birmingham,
AL) and was used as received. High-performance liquid chromotography
grade chloroform and methanol were purchased from Sigma Chemicals. All
experiments were performed using doubly glass-distilled deionized water,
the second distillation performed using dilute potassium permanganate (33).
DSC and FTIR
The hydrophobic constituents of BLES were extracted from the supplied
saline dispersion using a modiﬁed method (49) of Bligh and Dyer (50).
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Brieﬂy, the BLES dispersion was mixed with solvents to give a suspension
of chloroform/methanol/water, 2:1:0.1 (v/v), and the resulting chloroform-
rich phase was extracted. A second chloroform extract was performed on the
hydrophilic layer, and the chloroform-rich phases were combined (49).
Phosphorus was estimated from the organic extract by a modiﬁed method
(49) of Bartlett (51). Some of the organic extracts of BLES were analyzed
for a general molecular composition using electrospray ionization mass
spectrometry (ESI-MS) in the positive mode in a mass range of 400–1000
Da (16). The hydrophobic proteins were estimated using matrix-assisted
laser desorption-ionization time-of-ﬂight (MALDI-TOF) MS. Both these
methods as applied to LS are discussed in detail by others (52–54). To the
best of our knowledge, the detection of SP-B and SP-C directly from LS
extracts has not been done previously. However, MALDI-TOF has been
used to identify various forms and modiﬁed versions of the puriﬁed SP-B
and SP-C after isolation from the LS lipids (34,54).
This organic extract was then dried under a stream of nitrogen and left
overnight in vacuum in the dark to remove trace remnants of the solvents.
The dried extract was resuspended in saline to make samples for DSC and
FTIR by addition of water containing either 2 mM calcium chloride or 10%
by weight of albumin (1:0.1, BLES/albumin, dry wt/wt). The lipid-protein
system was incubated at 40C (above the phase transition of BLES) and
vortexed vigorously for 5 min. In certain cases, 8% by weight cholesterol
was added to the organic extract of BLES before drying and resuspension.
Transmission electron microscopy using methods discussed elsewhere (19)
suggested that these procedures yielded mostly MLVs in the dispersions,
which were similar to those seen in the originally supplied BLES dispersion.
The samples were diluted appropriately to concentrations of 2 mg/ml in
water for DSC and 6 mg/ml for FTIR. For DSC, the dispersions were
scanned at 60C/h in a DSC-2 differential scanning calorimeter (Microcal,
MA) over a range of 10–45C in three successive cycles by methods
discussed elsewhere (49). Samples were initially heated to 45C before
cooling to start the ﬁrst scan. Doubly distilled water was used as a reference.
No appreciable differences between the three cycles were noticed for BLES,
and only the third scans were used to compare calorimetric properties between
samples. For Fourier transform infrared (FTIR) spectrometry a liquid cell
containing ;50 ml (6 mg/ml) of sample was used in an FTIR spectrometer
(Bruker Tensor 27, Bruke, Billerica, MA) in the absorbance mode. The
intensity-wavenumber spectra were compared to those obtained from pure
water and the data displayed after subtracting the water spectrum from those
of the samples (55). The samples were scanned at a rate of 1 cm1/s, and 160
scans were integrated per sample at a temperature of 26C. The vibrational
frequency shift (in wavenumber) in the CH2 and CH3 symmetric and
asymmetric stretching modes of the acyl chains and the phosphate and
carboxyl stretching modes of the headgroup region were monitored using
methods previously developed by others (55–57).
2H-NMR
The samples for 2H-NMR were prepared from organic extracts, using a
higher concentration of BLES dissolved in chloroform/methanol. About 250
mg/ml of BLES lipids in chloroform/methanol was mixed with 7 mg of
DPPC-d62 (2.5% weight of BLES), and in certain cases 8% by weight
cholesterol was added to such mixtures. These organic extracts were dried
and then resuspended in water by methods similar to those used for prep-
aration of dispersions for DSC and FTIR. In some cases 10% albumin (1:0.1,
BLES/albumin, dry wt/wt) was dissolved in the water used for resuspension
of the dispersion. There was no appreciable difference in the calorimetrically
detectable broad transition of the DPPC-d62-BLES samples compared with
those measured for pure BLES. FTIR could detect the signal from the
carbon-deuterium (C-D) bond vibrations of the fatty acyl chains of the
DPPC-d62 (;2100 cm
1), at a separate wavenumber range from the carbon-
hydrogen or CH2 (2800 cm
1) bonds. Also, no signiﬁcant differences from
BLES alone were caused by incorporation of DPPC-d62 in the small amount
used.
Wideline 2H-NMR observations were made using a locally assembled
spectrometer operating in conjunction with a 9.4 T superconducting solenoid.
Spectra were obtained using a quadrupole echo pulse sequence (39) with p/2
pulse lengths of 4–5.5 ms, a pulse separation of 35 ms, and a repetition time
of 0.9 s. Depending on the sample, 16,000–48,000 transients were averaged
for each spectrum (40,41). Transients were oversampled (58) and digitized
with effective dwell times of 4 ms for spectra in the liquid-crystalline phase
and 2 ms for spectra displaying gel spectral features. Pulse lengths and
spectrometer frequency were carefully adjusted before acquisition to min-
imize signal in the imaginary channel. To facilitate calculation of ﬁrst moments,
spectra were then symmetrized by zeroing residual noise in the imaginary
channel before FTIR (40,41). No line broadening was applied.
RESULTS
The ESI-MS spectra of a), phospholipids, and b), MALDI-
MS spectra of proteins present in BLES are shown in Fig. 1.
The ESI-MS spectrum in positive ion mode shows the
relative distribution of positively charged, mainly phospho-
choline ions detected at varying mass/charge (m/z) ratios,
where z is 11. The main disaturated chain PCs found were
dipalmitoyl phosphatidylcholine or 16:0/16:0 PC (m/z ¼
734); palmitoyl-myrisitoyl- or 16:0/14:0-PC (or myristoyl-
palmitoyl, 14:0/16:0) PC (m/z ¼ 721). Other mono- and
diunsaturated species were mainly palmitoyl-palmitoleoyl- or
FIGURE 1 ESI-MS (a) and MALDI-TOF (b) spectra of BLES in organic
solvent obtained in the positive ion mode. The major phosphatidylcholine
species in panel a are detected as a singly charged species and represent the
major PC present in the lipid extract, and the 734 peak represents the 1,2,
dipalmitoylphosphatidylcholine (16:0/16:0 PC). The other species detected
with different acyl chain distribution of PC species at m/z are 706 (14:0/
16:0); 721 (16:0-sphigomyelin); 732 (16:0/16:1); 747-18:1-sphinogomyelin;
761- (16:0/18:1); 786- (18:2/18:2) phospholipids. In panel b the MALDI-
TOF spectra of BLES in organic solvent, the singly charged monomeric
species of bovine SP-C at 4041 Da, and SP-B monomers at 8.6 kDa and
dimers at 17.3 kDa are detected.
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16:0/16:1-PC (m/z ¼ 732), palmitoyl-oleoyl- or 16:0/18:1-
PC (m/z ¼ 761) or their positional isomers, and dioleoyl or
18:1/18:1-PC (m/z¼ 786) and minor amounts of other mixed
chain phospholipids. The two small peaks on the right side of
each major peak indicate phospholipid species which contain
one and two carbon-13 atoms (DPPC-734, -735, and -736) as
previously seen in ESI-MS used to identify singly or doubly
charged species in human surfactant (52,53). The acyl chain
distribution in BLES suggests that the mixture is mainly
composed of species which would give rise to ﬂuid and gel
phase polymorphism in a typical bilayer between 20–30C.
The species in bovine surfactant are also in close approx-
imation to those previously found in human (53), calf,
porcine, and some other mammalian LS extracts (32,53,59).
The MALDI-TOF spectrum in Fig. 1 b suggests the relative
amounts of the hydrophobic proteins present in BLES, with a
higher amount of SP-C (4041) and smaller amounts of SP-B
monomer (8676) and dimer (17,320) being seen. The molec-
ular weights of SP-C and SP-B are in close approximation
to those estimated using amino acid analysis (60) and in
isolated proteins from surfactants of other species (54).
DSC endotherms of vesicular dispersions of i), BLES, ii),
BLES with 8% by weight cholesterol, iii), BLES/cholesterol
1 2 mM calcium, and iv), BLES1 10 wt % albumin (1:0.1,
BLES/albumin, dry wt/wt) are shown in Fig. 2 a. The
endotherms show that the BLES dispersions undergo a broad
and diffuse phase transition between 10 and 35C, with a
Tmax around 27C. Addition of cholesterol to the BLES (ii)
and calcium ions in the subphase (iii) did not change the
endotherms signiﬁcantly, whereas a slight broadening of the
transition was observed for the samples containing albumin
(iv). The broadening suggests that albumin slightly affected
the chain packing of the phospholipids, consistent with
previous DSC studies on interaction of several water-soluble
proteins with phospholipid bilayers (24). However, in the
previous studies (24), the broadening of the transitions were
induced by ;100- to 1000-fold greater amounts of the sol-
uble proteins (at a ratio of 1:10, lipid/protein, wt/wt or
greater) than those used here.
The DSC (b) and FTIR (c) proﬁles of BLES-DPPC-d62
dispersions used for 2H-NMR experiments are also shown in
Fig. 2. The FTIR spectra were obtained at 26C, slightly
lower than the Tmax of the transition of BLES around 27C.
The FTIR spectra displayed were produced by subtracting
the spectra of pure doubly distilled water from the samples
spectra to suppress the effect of the intense broadbands
between 3000–2000 cm1 and 1700–1500 cm1 from water
(55,56). The upper FTIR spectrum in Fig. 2 c is for BLES,
and the bottom one is for BLES1DPPC-d62. The main peaks
between wave numbers 3000–2000 cm1 represent the CH2
(2922 cm1) and CH3 symmetric (Vs) and asymmetric (Vas)
vibrations, and those in the range of 1500–1000 cm1 are for
phosphate vibrational modes. The dispersions were highly
concentrated (250 mg/ml) to obtain appreciable NMR signals
from the small amounts of DPPC-d62, and they were diluted
to a concentration of 2–6 mg/ml to obtain the DSC and FTIR
scans. The two small additional peaks in the BLES-DPPC-
d62 FTIR spectra are from the Vs (2195 cm
1) and Vas (2050
cm1) modes of the C-D bonds of the DPPC-d62 incorpo-
rated in the samples. There was no appreciable difference in
either the Tmax of the phase transition in DSC (Fig. 2 b) or the
vibrational modes (Vs and Vas) of the acyl chains between
samples of BLES and those containing the added DPPC-d62,
suggesting that the deuterated phospholipid did not alter the
packing states of BLES bilayers signiﬁcantly. The spectrum
of a sample of BLES 1 albumin (data not shown) did not
show any shift of wavenumbers or appearance of new peaks,
and it was almost superimposable with those in Fig. 2 c.
Fig. 3 shows 2H-NMR spectra at selected temperatures for
DPPC-d62 incorporated into bilayers of BLES in water. Fig.
4 shows the spectra for (Fig. 4 a) BLES plus cholesterol
hydrated in water containing no Ca21; (Fig. 4 b) BLES plus
cholesterol hydrated in water containing 2 mM Ca21; and
(Fig. 4 c) BLES plus cholesterol hydrated in water con-
taining 2 mM Ca21 and serum albumin at a concentration
chosen to give a ratio of BLES/serum albumin of 1:0.1,
BLES/albumin (wt/wt). All of the spectra for 45C in Figs. 3
and 4 are superpositions of Pake doublets characteristic of
the fast, axially symmetric reorientation of C-D bonds typi-
cally observed in bilayer liquid-crystalline phases. The spectra
FIGURE 2 (a) DSC endotherms of i), BLES, ii), BLES with cholesterol,
iii), BLES with cholesterol and calcium, and iv), BLES with cholesterol,
calcium, and albumin (1:0.1, wt/wt). (b) DSC endotherm for BLES-DPPC-
d62. (c) The FTIR spectra of BLES (top) and BLES-DPPC-d62 (bottom). In
panel c the C-D2 symmetric and asymmetric stretching modes at 2195 cm
1
and 2090 cm1 appear as a separate pair of peaks due to the DPPC-d62
present in BLES; however, the relative distribution of the CH2 vibrations
(2922 and 2852 cm1) are not altered in either sample.
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at 0C are characteristic of intermediate rate reorientation on
the timescale of the experiment and are typical of bilayer gel
phases.
For the three samples containing no serum albumin (Figs.
3 and 4, a and b), evolution of the spectral shape from liquid-
crystal to gel-like proceeded continuously over a broad tem-
perature range as the sample was cooled. This could indicate
that all of the DPPC-d62 incorporated into the sample existed
in a uniform environment in which the lipid experienced a
continuous slowing of its reorientation and continuous in-
crease in chain order on cooling through the phase change.
An alternate possibility is that any coexisting domains of
ordered and ﬂuid lipid were small enough so that the DPPC-
d62 could sample and average all coexisting bilayer environ-
ments during the 70-ms duration of each experiment. These
are not mutually exclusive possibilities and it is not sur-
prising, given the complexity of the BLES composition, that
the average environment sampled by each lipid during an
experiment might change continuously on cooling.
For a given temperature above the transition midpoint, the
spectra of samples containing cholesterol and cholesterol
plus calcium displayed slightly larger splittings, primarily
reﬂecting the chain-ordering effect of cholesterol, but were
otherwise qualitatively similar to those of the BLES sample
alone. The prominent doublet with the smallest splitting in
each spectrum arises from the terminal methyl group of
DPPC-d62. It is interesting that from 20 to 30C, this splitting
was slightly larger in spectra from the sample containing
calcium and cholesterol (Fig. 4 b) than the spectra of BLES
plus cholesterol without calcium (Fig. 4 a). Even though the
BLES transition is very broad, this may reﬂect a slight
calcium-induced increase in the transition Tmax due to the
interactions of calcium with anionic lipids in the surfactant
extract (40,41,56). If such calcium-induced ordering of ionic
phospholipids (such as PG) in BLES occurred, it was not
apparent in other spectral features that were less sensitive to
gradual changes in the broad transition.
Spectra of the sample containing serum albumin (Fig. 4 c)
display qualitatively different behavior on cooling through
the temperature range over which the DPPC-d62 lipid probe
orders. Between 36 and 16C, the spectra for this sample
were superpositions of spectral components characteristic of
both gel and liquid-crystalline bilayer phases. A feature with
a splitting characteristic of gel phase DPPC-d62 methyl
deuterons became visible at 30C, and the prominent edge
characteristic of acyl chain plateau deuterons in the liquid-
crystalline phase remained visible even below 16C. This
implies that over this temperature range, DPPC-d62 was
partitioned between ordered and ﬂuid domains that were
large enough to preclude averaging by diffusion of the
FIGURE 3 2H-NMR spectra at selected temperatures for BLES-DPPC-d62
dispersions. Samples were cooled from 45 to 0C.
FIGURE 4 2H-NMR spectra at selected temperatures for BLES-DPPC-
d62 dispersions with (a) cholesterol, (b) cholesterol plus calcium, and (c)
cholesterol plus calcium plus albumin. Samples were cooled from 45 to 0C.
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DPPC-d62 molecules across domain boundaries during the
70-ms duration of the echo experiment. Using a diffusion
constant typical of lipids in liquid-crystalline phases, the area
sampled by a lipid in liquid-crystalline domains during
acquisition of a 2H-NMR signal has been estimated to be at
least 2.5 3 104 A˚2 (38). The persistence of a distinct liquid-
crystalline spectral component presumably indicates domains
of signiﬁcantly larger area. Given that the liquid-crystalline
spectral component was not signiﬁcantly broadened in com-
parison to samples without serum albumin, it seems unlikely
that the observation of distinct spectral components reﬂects a
protein-induced constraint on DPPC-d62 diffusion. It is more
likely that the presence of serum albumin in the aqueous
media contributed to the stabilization of relatively large
coexisting ordered and ﬂuid bilayer domains in the BLES/
cholesterol/Ca21 mixture. Coexistence of ordered and ﬂuid
domains over a broad temperature range for this sample was
conﬁrmed through a similar set of observations of a second
independent sample of similar composition.
It is interesting that the ﬂuid spectral component observed
in the presence of serum albumin in Fig. 4 b persisted down
to 16C, which is ;22C below the pure DPPC-d62 bilayer
transition. This suggests that the concentration of DPPC in
the ﬂuid phase was likely small compared to that of other,
presumably unsaturated lipids. It is also interesting that the
splitting displayed by the ﬂuid spectral component did not
increase signiﬁcantly as the temperature was lowered through
the broad two-phase coexistence region. Spectra character-
istic of coexisting ordered and ﬂuid phases were still seen
when the sample was thermally cycled back through the phase
transition, suggesting reversibility of the phase separation
induced by the albumin-BLES interaction.
For a spectrum f(v), the ﬁrst spectral moment is deﬁned as
M1 ¼
RN
0
vf ðvÞdv
RN
0
f ðvÞdv :
The ﬁrst moment is a measure of the average, over all
deuterated segments, of chain orientational order. Fig. 5
shows the temperature dependence of M1 for spectra of
DPPC-d62 from the four samples represented in Figs. 3 and
4. The gradual increase inM1 as the BLES-DPPC-d62 sample
was cooled from;31 to;10C reﬂects the very broad phase
change expected for a mixture containing saturated and
unsaturated phospholipids as well as small concentrations of
the hydrophobic surfactant proteins SP-B and SP-C (40).
The high-temperature and low-temperature values of M1 are
typical of liquid-crystal and gel phase bilayers containing
lipid with perdeuterated saturated chains. Addition of cho-
lesterol increased chain order slightly for all temperatures.
This is consistent with the cholesterol-induced ordering of
simpler bilayers containing DPPC-d62 (37). The presence of
Ca21 in the aqueous phase has little additional effect on the
average chain order of the BLES-DPPC-d62-cholesterol
sample.
The presence of serum albumin in the aqueous phase did
alter the temperature dependence of the ﬁrst spectral moments
somewhat as seen in Fig. 5 (solid circles). Above the broad
phase change, the values of M1 for BLES-DPPC-d62 plus
cholesterol in the presence of serum albumin were closer to
those of BLES-DPPC-d62 than to those of BLES-DPPC-d62
plus cholesterol. The inﬂuence of serum albumin, along with
Ca21, appears to counteract some of the cholesterol-induced
ordering. At low temperatures, the ﬁrst moments of spectra
for the sample containing serum albumin were lower than
those for BLES-DPPC-d62 as well as those for BLES-DPPC-
d62 plus cholesterol. This is perhaps not surprising given the
observation that serum albumin promotes the persistence of a
ﬂuid spectral component to lower temperatures. It is striking,
however, that despite the presence of a ﬂuid spectral component,
the ﬁrst spectral moments for the sample containing serum
albumin (Fig. 5, closed circles) were slightly higher for the
intermediate temperatures corresponding to the midrange of
the broad transition. This is consistent with the small step in
ﬁrst spectral moment between 36 and 33C near the onset of
the transition. Presumably this indicates the rapid initial
growth of ordered domains followed by the slow transfer of
remaining ﬂuid material to ordered phase domains over the
rest of the broad transition temperature range.
DISCUSSION
LS has an unusual lipid-protein composition compared to
most biological membranes (1). It has been suggested that
the individual lipids and hydrophobic proteins contribute to
its surface activity in speciﬁc ways. The disaturated lipids
such as DPPC mainly enable tight packing of the lipids in
FIGURE 5 Temperature dependence of 2H-NMR ﬁrst spectral moments
(M1) for (s) BLES, (h) BLES-cholesterol, (n) BLES-cholesterol-calcium,
and (d) BLES-cholesterol-calcium-albumin samples containing DPPC-d62.
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ﬁlms (1,2). Because DPPC ﬁlms can be compressed to high
surface pressures (70 mN/m), surface tension at an air-water
interface containing a DPPC monolayer can approach values
close to 0 mN/m (2). However DPPC adsorbs and respreads
slowly at an air-water interface. Studies of model surfactant
materials and materials based on surfactant lung washings
and extracts suggest that the presence of more ﬂuid lipids,
such as 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC),
and of hydrophobic proteins contribute to the rapid adsorp-
tion and respreading of the native LS ﬁlms (3). The ESI mass
spectra of BLES suggest the presence of almost equiv-
alent amounts of saturated as well as unsaturated acyl chain
phosphatidylcholines in the surfactant (Fig. 1). Although
DPPC has been consistently suggested to be the main surfac-
tant component with a sufﬁciently high gel-ﬂuid transition
temperatureof 41oC to allow for optimal surface activity, other
disaturated components such as 1-palmitoyl-2-myristoyl phos-
phatidylcholine (16:0/14:0-PC) or 1-myristoyl-2-palmitoyl
phosphatidylcholine (14:0/16:0-PC), and monounsaturated
species, most likely 1-palmitoyl-2-palmitoleyl-phosphatidy-
choline (PPPC) (16:0/16:1-PC) and POPC (16:0/18:1-PC),
are also present in signiﬁcant amounts (52,53). Recently a
study has shown that surfactants from some mammalian
species such as dunnart and squirrel contain higher amounts
of PPPC than DPPC (59). However these LS do not have
compromised surface activity since higher amounts of
cholesterol are present in surfactant of some of these animals
(59). It appears that ﬂuidity is tightly controlled is most mam-
malian surfactant (3). Recent work by Hall and colleagues
has also suggested that under sufﬁciently fast compression,
ﬁlms that have mixtures of ﬂuid and rigid lipids could sustain
high surface pressures with corresponding low surface ten-
sions (35,61).
Many 2H-NMR studies are done with synthetic perdeu-
terated phospholipids as the major component of mixed lipid
model systems (39–41). However introduction of any probe
to a more natural system such as BLES may cause perturba-
tions. Comparative studies of BLES with those containing
the DPPC-d62 probe were done using DSC and FTIR. The
DSC proﬁles of the BLES-DPPC-d62 (Fig. 2 b), as well as
the FTIR spectra (Fig. 2 c), suggested that incorporation of
the DPPC-d62 did not alter either the midpoint of the tran-
sition or the standard methylene and methyl symmetric
vibrational modes of BLES phospholipids. The CH2 sym-
metric vibrational modes of phospholipids are highly sus-
ceptible to levels of trans-gauche isomerization (57). The
FTIR spectra of the C-D vibrational modes from the DPPC-
d62 incorporated in BLES show a similar distribution of the
C-D modes or C-H modes in BLES alone, suggesting that
the probe’s fatty acyl chains were in similar conformations as
those of native phospholipids present in BLES. Our study
suggests that natural systems such as membrane extracts and
LS can be studied using 2H-NMR, although with certain
constraints such as the difﬁculty of detecting signal from the
small amounts of ‘‘deuterated probe’’ molecules.
The heterogeneity of the lipid chain distribution in sur-
factant material raises the likelihood of phase separation in
bothmonolayer and bilayer environments.Monolayer studies
have shown that such phase segregation is observed as the
coexistence of gel-like (condensed) and ﬂuid (expanded)
domains in porcine (32,33), calf (35), and rat (62) surfac-
tant extracts. These domains were also observed in giant
unilamellar bilayer of BLES (18) and MLVs of porcine LS
(25) close to the physiological temperature of 37C. From
imaging methods, the upper limit for gel or condensed phase
in LS extract monolayers has been estimated to be 25–30%,
which is close to the total amounts of DPPC detectable in
these surfactants (33–35,62). Previous studies have sug-
gested that although small amounts of hydrophobic proteins
SP-B and SP-C signiﬁcantly enhance surfactant lipid surface
activity in model lipid mixtures, their concentration in native
surfactant (2–3 wt % of lipids) may not signiﬁcantly change
the gel-ﬂuid status of the material (Fig. 1 b) (3).
Previous studies of GUV of BLES have shown the
presence of gel and liquid-crystalline domains between
37–10C during cooling (18). Using two-photon ﬂuores-
cence microscopy, the gel domains were found to be cou-
pled between the hemilayers of the BLES bilayers, as seen
also in other synthetic gel-ﬂuid lipid mixtures and mem-
brane lipid raft models (63). The DPPC-d62 spectra shown
in Fig. 3 are typical of a liquid-crystalline phase at higher
temperatures and of a gel-like phase at lower temperatures.
The spectra at intermediate temperatures do not show any
superposition of spectral features that would indicate co-
existence of large liquid-crystalline and gel domains. Al-
though such a continuous change of spectral shape could
simply indicate a gradual ordering and slowing of chain
motions without phase coexistence, it could also result from
the coexistence of domains that are small enough to allow
all diffusing lipids to sample equivalent average environ-
ments over the microsecond timescale of the 2H-NMR time-
scale of the experiment.
Cholesterol is an important constituent of most eukaryotic
cell membranes, and its effects on biological membrane
properties have been extensively studied. However its role in
LS is not clear (1,30,64–66). Removal of cholesterol during
the preparation of BLES is thought to enhance its surface
efﬁcacy as a clinical replacement surfactant (10). Reintro-
ducing cholesterol to BLES provides a way to study the
effects of this neutral lipid on phospholipid chain confor-
mation in surfactant (25,30,35,66). Some have suggested
that cholesterol is not an integral component of surfactant but
is introduced into the surfactant pool from lipoproteins (64).
It is further suggested that cholesterol contributes minimally
to surfactant activity at the levels present in bovine surfactant
(64–66). However a recent article by Serna et al. (25) sug-
gests that the phase transition process in LS, as reﬂected by
formation of macroscopic domains in giant vesicles, is al-
tered signiﬁcantly by addition and removal of small amounts
of cholesterol. In these vesicles of porcine lavage surfactant
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(containing all components of surfactant including SP-A and
SP-D), Lo and liquid-crystalline domains are observed to
coexist at 37C. Removal of cholesterol using cyclodextrin
results in a change toward coexistence of gel and liquid-
crystalline domains, as also seen in our study with BLES
which is devoid of cholesterol.
Numerous studies have shown that for concentrations
below 10%, cholesterol generally leads to ordering of phos-
pholipids in the ﬂuid or liquid-crystalline phase while en-
hancing ﬂuidity in the gel phase. 2H-NMR studies suggest
that in disaturated lipids like DPPC, cholesterol orders the
chains in the gel as well as liquid-crystalline phase (37,67).
Like the DPPC-d62 spectra obtained from BLES alone, the
DPPC-d62 spectra from BLES with cholesterol are not
superpositions of distinct liquid-crystal and gel-like compo-
nents. As such, they do not provide clear evidence for
coexisting gel and liquid-crystal-like domains. The DSC
proﬁles of BLES with cholesterol (Fig. 2 a), however, do
show a slight increase (2–3C) in the Tmax in comparison to
those of BLES alone. Fig. 5 shows that addition of choles-
terol to BLES results in consistently higher ﬁrst spectral
moments, and thus average order parameters, throughout the
temperature range studied.
Addition of calcium ions does not seem to change either
the spectral shape or the average orientational order of the
probe DPPC-d62 chains. The slight increase in methyl group
quadrupole splitting near the transition midpoint may reﬂect
a small calcium-induced condensation of the bilayer. Some
previous studies have shown calcium ions to have additional
ordering effects on various surfactant lipid extracts in mono-
layers as well as bilayers (33,36,56). BLES contains nega-
tively charged phospholipids such as PG, and most previous
studies have suggested that divalent cations interact strongly
with such charged headgroups (65,68–70). This is consistent
with earlier 2H-NMR studies that showed a calcium-induced
increase in chain order in DPPC/DPPG mixtures (40–42).
It has also been observed that the effect of calcium on the
ordering of C-D methylene bonds is more pronounced at the
C2–C7 positions than in the bilayer core CH3 group (67,68).
The effect was seen as a lateral ‘‘area compression’’ of the
bilayers (68,70). Other studies showed that such calcium-
induced lateral area compressions occur in monolayers of
DPPC:PG (69–71) and also in LS ﬁlms as seen by a 10%
increase in the total amount of condensed (gel-like) phase
with calcium in the hypophase (33).
Addition of serum albumin to the BLES bilayers resulted
in a slight broadening of the DSC proﬁles, although no
change of transition midpoint is noticeable (Fig. 2 a). This is
consistent with the effect of water-soluble proteins on simple
lipid bilayers as monitored using DSC (24). The most strik-
ing effect of adding serum albumin was to give rise to distinct
gel and liquid-crystalline DPPC-d62 spectral components
over a temperature range of 20–30C. The most likely
explanation for this observation is that the presence of the
serum albumin promoted the growth of coexisting domains
to a size such that diffusion across domain boundaries was
insufﬁcient to result in all DPPC-d62 experiencing the same
average environment on the;105 s timescale of the 2H-NMR
experiment. It is interesting to note here that, at least in this
BLES-serum albumin mixture where there is a ratio of 10:1,
lipid/protein (wt/wt), albumin seems to affect the phospho-
lipid environment to promote persistence of domains which
are large enough to not allow full diffusion of the DPPC
probe across domain boundaries at NMR timescales.
Previous studies of ARDS and LS dysfunction models
have suggested that serum albumin can inhibit the surface
activity of various surfactant extracts as well as model lipid-
surfactant protein systems (reviewed in Greise (6), Holm (8),
and McLean and Lewis (13)). However in some of these
studies it was also noted that inhibition of surface activity as
monitored by decrease in adsorption to form ﬁlms and
inability of such ﬁlms to reach low surface tension required
large amounts of the inhibitory proteins (1:10 and 1:20, LS-
lipid/protein, wt/wt) (6). In some studies, by increasing the
concentration of surfactant to inhibitory protein from 1:10 to
1:1, this inhibition could be abolished (8,12,72,73). However
in cell-free LS or large aggregate LS from lung washings,
lipid/soluble protein ratios are generally estimated to be
;3:1 (wt/wt) (6–9) and in the case of ARDS or injured
lungs, these ratios hardly exceed;1:1 (7,9,62). It is not clear
why LS from such diseased lung washings show extremely
poor surface activity, reminiscent of the activity shown in the
laboratorywith nonphysiological or nonpathological amounts
of soluble proteins. A recent study using minor amounts of
albumin in preformed model LS ﬁlms has suggested that
there are dramatic changes in the monolayer collapse
behavior and monolayer viscosity (26). In that study, it was
suggested that albumin possibly altered the phase transition
proﬁles of the model surfactant lipids and thus decreased the
rate of respreading of thematerial when such ﬁlmswere cycled
at an air-water interface (26,74). Our study of surfactant
bilayers could support this interpretation. Other studies have
suggested that the effect of albumin can be reversed by either
using high amounts of SP-A (17) or cationic polymers (36).
Comparing Langmuir ﬁlms of large aggregate LS from
hyperventilation-injured lungs with those from normal lungs,
large proteinaceous domains were detected in the ﬁlms from
injured lungs using atomic force microscopy (32,62). Also, a
signiﬁcant decrease of condensed or gel-like domains (30%–
3%) was noted in the LS from injured lungs compared to the
normal (32). Caution is required when comparing LS bilayer
studies with those from monolayers. However in light of
some correlated studies which have shown similarity in
structural organization of LS lipids in gel and ﬂuid domains
in monolayers as well as bilayers (25), it is reasonable to
assume that albumin which perturbs monolayer packing (36)
would also affect the LS in bilayers. Another study of BLES,
performed in a capillary surfactometer, shows a sharp change
of airway opening proﬁle in the gel to ﬂuid phase transition
(20–30C) range of BLES (75). The temperature dependence
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of airway opening is similar to the temperature dependence
of 2H-NMR ﬁrst spectral moments for BLES containing
DPPC-d62 (Fig. 5), as well as the DSC heat-ﬂow proﬁles of
BLES as detailed elsewhere (34). It is interesting to note that
in the upper airway model study (75), albumin altered the
airway opening proﬁle quite dramatically, making the sharp
changes of airway opening more diffuse than those obtained
from BLES alone (75). In that study, the change of LS by
albumin was suggested to have some implication for the
understanding of exercise-induced asthma (75). These studies
and ours suggest that albumin perturbs the packing of lipids
and thereby the molecular lipid motions related to the tran-
sition of LS (26,32,36,62,75). Some previous studies have
suggested that this sort of disruption of lipid rearrangement
can eventually lead to gradual loss of functionality in LS
(14,26,34,36) as well as in other membranous systems (29,76).
This study suggests that a gel to liquid-crystalline phase
change occurs in BLES over a broad temperature range and
that it can be monitored by complementary techniques such
as DSC and 2H-NMR. Also, incorporation of a small amount
of the PDL (DPPC-d62) as a probe in such systems does not
signiﬁcantly alter the transition characteristics. Calcium and
cholesterol increase the order parameter of lipid chains as
reported by chains of the DPPC-d62 probe molecules. Intro-
duction of albumin in such systems seems to lead to possible
induction of speciﬁc lipid-soluble protein domain formation
which persists over a limited temperature range. Such an
albumin-induced change in the distribution and motion of
lipids in LS could contribute to the negative effect of
albumin on biophysical activities of the material in patho-
physiological conditions.
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